Literature DB >> 18377807

IBD in children: lessons for adults.

Cindy A Haller1, James Markowitz.   

Abstract

When children develop inflammatory bowel disease (IBD), physicians and researchers are presented with a singular opportunity to understand the nature of these chronic, idiopathic illnesses in the earliest stages. Genetic susceptibility factors tend to be common, whereas complicating environmental factors such as cigarette smoking are generally not an issue. As opposed to the case in adult patients, Crohn's disease is usually diagnosed in children at an early, inflammatory phase of the disease. Pediatric ulcerative colitis tends to present with more severe and more extensive involvement than in adults. In both forms of IBD, the severity of disease activity often dictates the need for early aggressive nutritional, immunomodulatory, and biologic therapy. As a result, the lessons learned from the evaluation and treatment of children with IBD are critically important to the clinician caring for adults with the same disorders.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18377807     DOI: 10.1007/s11894-007-0070-8

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  41 in total

1.  Use of infliximab in the treatment of Crohn's disease in children and adolescents.

Authors:  J S Hyams; J Markowitz; R Wyllie
Journal:  J Pediatr       Date:  2000-08       Impact factor: 4.406

2.  Polymeric diet alone versus corticosteroids in the treatment of active pediatric Crohn's disease: a randomized controlled open-label trial.

Authors:  Osvaldo Borrelli; Letizia Cordischi; Manuela Cirulli; Massimiliano Paganelli; Valeria Labalestra; Stefania Uccini; Paolo M Russo; Salvatore Cucchiara
Journal:  Clin Gastroenterol Hepatol       Date:  2006-05-06       Impact factor: 11.382

3.  Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci.

Authors:  J D Rioux; M S Silverberg; M J Daly; A H Steinhart; R S McLeod; A M Griffiths; T Green; T S Brettin; V Stone; S B Bull; A Bitton; C N Williams; G R Greenberg; Z Cohen; E S Lander; T J Hudson; K A Siminovitch
Journal:  Am J Hum Genet       Date:  2000-04-21       Impact factor: 11.025

4.  National Cooperative Crohn's Disease Study: results of drug treatment.

Authors:  R W Summers; D M Switz; J T Sessions; J M Becktel; W R Best; F Kern; J W Singleton
Journal:  Gastroenterology       Date:  1979-10       Impact factor: 22.682

5.  Serum immune responses predict rapid disease progression among children with Crohn's disease: immune responses predict disease progression.

Authors:  Marla C Dubinsky; Ying-Chao Lin; Debra Dutridge; Yoana Picornell; Carol J Landers; Sharmayne Farrior; Iwona Wrobel; Antonio Quiros; Eric A Vasiliauskas; Bruce Grill; David Israel; Ron Bahar; Dennis Christie; Ghassan Wahbeh; Gary Silber; Saied Dallazadeh; Praful Shah; Danny Thomas; Drew Kelts; Robert M Hershberg; Charles O Elson; Stephan R Targan; Kent D Taylor; Jerome I Rotter; Huiying Yang
Journal:  Am J Gastroenterol       Date:  2006-02       Impact factor: 10.864

6.  Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children.

Authors:  Jeffrey Hyams; Wallace Crandall; Subra Kugathasan; Anne Griffiths; Allan Olson; Jewel Johanns; Grace Liu; Suzanne Travers; Robert Heuschkel; James Markowitz; Stanley Cohen; Harland Winter; Gigi Veereman-Wauters; George Ferry; Robert Baldassano
Journal:  Gastroenterology       Date:  2006-12-03       Impact factor: 22.682

7.  CARD15 gene mutations and risk for early surgery in pediatric-onset Crohn's disease.

Authors:  Subra Kugathasan; Nicole Collins; Karen Maresso; Raymond G Hoffmann; Michael Stephens; Steven L Werlin; Colin Rudolph; Ulrich Broeckel
Journal:  Clin Gastroenterol Hepatol       Date:  2004-11       Impact factor: 11.382

8.  Corticosteroid therapy in the age of infliximab: acute and 1-year outcomes in newly diagnosed children with Crohn's disease.

Authors:  James Markowitz; Jeffrey Hyams; David Mack; Neal Leleiko; Jonathan Evans; Subra Kugathasan; Marian Pfefferkorn; Adam Mezoff; Joel Rosh; Vasundhara Tolia; Anthony Otley; Anne Griffiths; M Susan Moyer; Maria Oliva-Hemker; Robert Wyllie; Robert Rothbaum; Athos Bousvaros; J Fernando Del Rosario; Sandra Hale; Trudy Lerer
Journal:  Clin Gastroenterol Hepatol       Date:  2006-07-24       Impact factor: 11.382

9.  Epidemiologic and clinical characteristics of children with newly diagnosed inflammatory bowel disease in Wisconsin: a statewide population-based study.

Authors:  Subra Kugathasan; Robert H Judd; Raymond G Hoffmann; Janice Heikenen; Gregorz Telega; Farhat Khan; Sally Weisdorf-Schindele; William San Pablo; Jean Perrault; Roger Park; Michael Yaffe; Christopher Brown; Maria T Rivera-Bennett; Issam Halabi; Alfonso Martinez; Ellen Blank; Steven L Werlin; Colin D Rudolph; David G Binion
Journal:  J Pediatr       Date:  2003-10       Impact factor: 4.406

10.  Adult height in patients with early onset of Crohn's disease.

Authors:  N Alemzadeh; L T M Rekers-Mombarg; M L Mearin; J M Wit; C B H W Lamers; R A van Hogezand
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

View more
  5 in total

1.  Can nutritional therapy replace pharmacologic therapy in pediatric Crohn's disease?

Authors:  Miquel A Gassull
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2008-12-23

2.  Quality of Life in Swiss Paediatric Inflammatory Bowel Disease Patients: Do Patients and Their Parents Experience Disease in the Same Way?

Authors:  Rebekka Mueller; Farah Ziade; Valérie Pittet; Nicolas Fournier; Jessica Ezri; Alain Schoepfer; Susanne Schibli; Johannes Spalinger; Christian Braegger; Andreas Nydegger
Journal:  J Crohns Colitis       Date:  2015-10-29       Impact factor: 9.071

3.  Direct health care costs of Crohn's disease and ulcerative colitis in US children and adults.

Authors:  Michael D Kappelman; Sheryl L Rifas-Shiman; Carol Q Porter; Daniel A Ollendorf; Robert S Sandler; Joseph A Galanko; Jonathan A Finkelstein
Journal:  Gastroenterology       Date:  2008-09-17       Impact factor: 22.682

4.  The Increased Expression of CCL20 and CCR6 in Rectal Mucosa Correlated to Severe Inflammation in Pediatric Ulcerative Colitis.

Authors:  Keiichi Uchida; Yuhki Koike; Kiyoshi Hashimoto; Susumu Saigusa; Mikihiro Inoue; Kohei Otake; Koji Tanaka; Kohei Matsushita; Yoshiki Okita; Hiroyuki Fujikawa; Toshimitsu Araki; Yasuhiko Mohri; Masato Kusunoki
Journal:  Gastroenterol Res Pract       Date:  2015-01-27       Impact factor: 2.260

Review 5.  The "Gum-Gut" Axis in Inflammatory Bowel Diseases: A Hypothesis-Driven Review of Associations and Advances.

Authors:  Kevin M Byrd; Ajay S Gulati
Journal:  Front Immunol       Date:  2021-02-19       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.